1-7 of 7
XianQi Feng
Close
Sort by
Journal Articles

Efficacy and Safety Analysis of Carfilzomib-Containing Regimen in the Treatment of Multiple Myeloma：a Multicenter Real-World Study

Na Liu, Luqun WANG, Rentong Liu, Yuping Zhong, Xianqi Feng, Zhongliang Sun, Jie Li, Fanjun Meng, Junjie MA, Changyong Yuan, Hao Li, Ling Wang, Zhilong Xu, Jie Yu, Hao Zhang, Chen Chunyan
Journal: Blood
Blood (2023) 142 (Supplement 1): 6632.
https://doi.org/10.1182/blood-2023-179687
Published: 2023
Journal Articles

Efficacy and Safety of Clifutinib, a Novel, Highly Selective, Oral FLT3 Inhibitor, in Patients with FLT3-Mutated Relapsed or Refractory Acute Myeloid Leukemia：Updated Results from a Phase I Study

Jie Jin, Huafeng Wang, Wen-Juan Yu, Zheng Ge, Xudong Wei, Yuhua Li, Zhongxing Jiang, Yiqing Li, Xin Du, Linhua Yang, Lie Lin, Jishi Wang, Yazhou Yao, Xiaoping Hu, Jianping Lan, Xiuzhi Deng, Tong Chen, Xianqi Feng, Dengju Li, Ming Hou, Rong Fu, Siyong Huang, Jingbo Wang, Xin Du, Hui Yang, Haiping Yang, Yingzhi Jiang, Zhijie Wang, Deng Li, Bing Liu, Ning Kang, Yulei Zhuang, Yingjun Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4281.
https://doi.org/10.1182/blood-2023-188961
Published: 2023
Journal Articles

Pharmacokinetics, Safety and Preliminary Efficacy of Multiple Doses of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW117) in Previously Treated Adult and Adolescent Subjects with Severe Hemophilia a: Results from an Open-Label, Multicenter, Phase 2 Study

Feng Xue, Weizhi Chen, Shuxia Guo, Haiying Hua, Yu Cao, Xianqi Feng, Renchi Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 2615.
https://doi.org/10.1182/blood-2023-180649
Published: 2023
Journal Articles

Update Results of a Phase II Trial of Venetoclax in Combination with Azacitidine and Chidamide in Relapsed/Refractory Acute Myeloid Leukemia

Jie Zha, Ying Wang, Zhenling Li, Zhijuan Lin, Yun Cai, Tiejun Gong, Wei Yang, Siting Xie, Zhenqi Huang, Pengcheng SHI, Lin Fu, Jinghua Wang, Xiangjun Fu, Xianqi Feng, Liping Su, Jianmin Luo, Lin Yang, Biyun Chen, Ying Xie, Yu Zhu, Xin Du, Yirong Jiang, Zhifeng Li, Bing Xu
Journal: Blood
Blood (2023) 142 (Supplement 1): 4274.
https://doi.org/10.1182/blood-2023-182832
Published: 2023
Journal Articles

Preclinical Studies and Phase II Trial of Venetoclax in Combination with Chidamide and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia

Jie Zha, Hui Zhou, Mengya Zhong, Ying Wang, Xin Du, Tiejun Gong, Zhijuan Lin, Yun Cai, Siting Xie, Chendi Xie, XianQi Feng, ZhenQi Huang, Liping Su, Jianmin Luo, Lin Yang, Zhenling Li, Bi-yun Chen, Ying Xie, Yu Zhu, Pengcheng Shi, Zhifeng Li, Yirong Jiang, Bing Xu
Journal: Blood
Blood (2022) 140 (Supplement 1): 3292–3293.
https://doi.org/10.1182/blood-2022-165261
Published: 2022
Journal Articles

Orelabrutinib in Combination with Rituximab and Chemotherapy for Newly Diagnosed Aggressive B-Cell Lymphoma: A Multicenter, Single-Arm, Prospective Study

Xiangxiang Zhou, Xiaoqian Liu, Yurou Chu, Xiaoxia Chu, Jie Li, Haiyan Zhang, Changyong Yuan, Xiuzhi Deng, Guoqiang Liu, XianQi Feng, Wei Wang, Zhaogang Sun, Xiaosheng Fang, Mei Ding, Dai Yuan, Xueling Ge, Ying Li, Xin Liu, Lingyan Zhang, Xin Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 9544–9545.
https://doi.org/10.1182/blood-2022-169274
Published: 2022
Journal Articles

Novel Fusion Genes Involving Hnrnpc and Rarg in Acute Myeloid Leukemia Mimicking Acute Promyelocytic Leukemia

Zhan Su, MD, Xin Liu, MD PhD, Yan Xu, MD, Weiyu Hu, MD, Chunting Zhao, MD, Hongguo Zhao, MD, Xianqi Feng, MD, Shuchao Zhang, Jie Yang, Xue Shi, Lugui Qiu, MD PhD, Jun Peng, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5274.
https://doi.org/10.1182/blood-2018-99-111433
Published: 2018